Healthcare provider profile · identity verified

Stuart James Kanter, DO

Family Practice · GRANVILLE, OH · NPI 1730122193

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	434	75
Levothyroxine Sodium	Levothyroxine Sodium	350	62
Sertraline Hcl	Sertraline Hcl	337	47
Amlodipine Besylate	Amlodipine Besylate	313	52
Furosemide	Furosemide	296	46
Eliquis	Apixaban	288	52
Gabapentin	Gabapentin	252	44
Donepezil Hcl	Donepezil Hcl	217	36
Losartan Potassium	Losartan Potassium	216	37
Metoprolol Succinate	Metoprolol Succinate	208	39
Omeprazole	Omeprazole	188	37
Trazodone Hcl	Trazodone Hcl	184	27
Metoprolol Tartrate	Metoprolol Tartrate	169	28
Pantoprazole Sodium	Pantoprazole Sodium	168	28
Lisinopril	Lisinopril	164	33
Clopidogrel	Clopidogrel Bisulfate	163	28
Famotidine	Famotidine	150	17
Quetiapine Fumarate	Quetiapine Fumarate	139	28
Potassium Chloride	Potassium Chloride	132	25
Escitalopram Oxalate	Escitalopram Oxalate	125	22
Carvedilol	Carvedilol	123	16
Tamsulosin Hcl	Tamsulosin Hcl	121	22
Memantine Hcl	Memantine Hcl	119	17
Mirtazapine	Mirtazapine	109	23
Divalproex Sodium	Divalproex Sodium	98	17
Carbidopa-Levodopa	Carbidopa/Levodopa	93	16
Finasteride	Finasteride	89	12
Simvastatin	Simvastatin	89	15
Levetiracetam	Levetiracetam	88	12
Buspirone Hcl	Buspirone Hcl	87	16
Tradjenta	Linagliptin	83	suppressed
Tramadol Hcl	Tramadol Hcl	79	12
Spironolactone	Spironolactone	78	12
Latanoprost	Latanoprost	73	12
Pravastatin Sodium	Pravastatin Sodium	73	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	58	suppressed
Alendronate Sodium	Alendronate Sodium	57	15
Duloxetine Hcl	Duloxetine Hcl	57	11
Allopurinol	Allopurinol	54	12
Nifedipine Er	Nifedipine	52	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	52	11
Metformin Hcl	Metformin Hcl	50	15
Venlafaxine Hcl Er	Venlafaxine Hcl	48	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	suppressed
Meloxicam	Meloxicam	45	12
Oxybutynin Chloride Er	Oxybutynin Chloride	45	suppressed
Bupropion Xl	Bupropion Hcl	41	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	41	17
Venlafaxine Hcl	Venlafaxine Hcl	39	suppressed
Warfarin Sodium	Warfarin Sodium	39	suppressed
Amiodarone Hcl	Amiodarone Hcl	37	suppressed
Citalopram Hbr	Citalopram Hydrobromide	37	suppressed
Metformin Hcl Er	Metformin Hcl	37	suppressed
Torsemide	Torsemide	37	11
Bupropion Hcl Sr	Bupropion Hcl	36	suppressed
Lamotrigine	Lamotrigine	36	suppressed
Oxycodone Hcl	Oxycodone Hcl	36	14
Baclofen	Baclofen	35	suppressed
Digoxin	Digoxin	35	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	34	suppressed
Fluticasone Propionate	Fluticasone Propionate	34	12
Ondansetron Hcl	Ondansetron Hcl	34	28
Bethanechol Chloride	Bethanechol Chloride	32	suppressed
Nystatin	Nystatin	32	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	29	suppressed
Atenolol	Atenolol	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	11
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Prednisone	Prednisone	25	12
Diltiazem 24hr Er	Diltiazem Hcl	24	suppressed
Methenamine Hippurate	Methenamine Hippurate	24	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Loperamide	Loperamide Hcl	23	12
Carbidopa-Levodopa Er	Carbidopa/Levodopa	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	13
Haloperidol	Haloperidol	20	suppressed
Lacosamide	Lacosamide	20	suppressed
Lorazepam	Lorazepam	20	18
Montelukast Sodium	Montelukast Sodium	20	suppressed
Glimepiride	Glimepiride	19	suppressed
Memantine Hcl Er	Memantine Hcl	19	suppressed
Perphenazine	Perphenazine	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Risperidone	Risperidone	19	suppressed
Admelog	Insulin Lispro	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Galantamine Er	Galantamine Hbr	18	suppressed
Bumetanide	Bumetanide	17	suppressed
Diazepam	Diazepam	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Anastrozole	Anastrozole	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	11
Celecoxib	Celecoxib	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Raloxifene Hcl	Raloxifene Hcl	14	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Carbamazepine	Carbamazepine	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	11
Risperidone Odt	Risperidone	13	suppressed
Rivastigmine	Rivastigmine	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Topiramate	Topiramate	13	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	13	suppressed
Azathioprine	Azathioprine	12	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Glipizide	Glipizide	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Ramipril	Ramipril	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Timolol Maleate	Timolol Maleate	12	suppressed
Valsartan	Valsartan	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Fluvoxamine Maleate Er	Fluvoxamine Maleate	11	suppressed
Otezla	Apremilast	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error